• Minna E Kubin, Päivi M Hägg, Nina Kokkonen, Kirsi-Maria Haapasaari, Juha P Väyrynen, Tatsuya Uchida, Virpi Glumoff, Petri Kulmala, Tiina Hurskainen, and Kaisa Tasanen.
• Department of Dermatology, University of Oulu, FIN-90029 Oulu, Finland. minna.kubin@ppshp.fi.
• Acta Derm. Venereol. 2016 Nov 2; 96 (7): 922-926.

AbstractFirst-line treatments of bullous pemphigoid (BP) are topical and systemic glucocorticoids (GC). The actions of GC are mediated by glucocorticoid receptors (GR), which exist in several isoforms, of which GRα and GRβ are the most important. In many inflammatory diseases, up-regulation of GRβ is associated with GC insensitivity. The aims of this study were to determine the expression of GRα and GRβ in patients with BP and to investigate the effect of prednisolone treatment on the expression of GR isoforms in BP. Quantitative real-time PCR (qPCR) analysis demonstrated that GR isoform mRNAs are expressed in peripheral blood mononuclear cells (PBMC) from patients with BP. Expression of GRα and GRβ protein was confirmed by immunohistochemical staining of BP skin biopsies and by Western blot analysis and flow cytometric analysis of PBMCs. During prednisolone treatment, GRα and GRβ expression varied markedly, but changes were not suitable as a clinical marker of GC sensitivity in patients with BP.

25 keywords...

hide…